TY  - RPRT
TI  - Deep Learning-Driven Discovery of FDA-Approved BCL2 Inhibitors: In Silico Analysis Using a Deep Generative Model NeuralPlexer for Drug Repurposing in Cancer Treatment
AU  - Sayyah, E.
AU  - Tunc, H.
AU  - DURDAGI, S.
PY  - 2024
DO  - 10.1101/2024.07.15.603544
UR  - https://www.biorxiv.org/content/10.1101/2024.07.15.603544v1
ID  - 10.1101/2024.07.15.603544
ER  -